Cite
HARVARD Citation
Czerniak, R. et al. (2022). The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK‐954). Journal of clinical pharmacology. pp. 1006-1017. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Czerniak, R. et al. (2022). The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK‐954). Journal of clinical pharmacology. pp. 1006-1017. [Online].